180 related articles for article (PubMed ID: 2066105)
1. CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series.
Chen SH; Zhang M; Lovrien EW; Scott CR; Thompson AR
Hum Genet; 1991 Jun; 87(2):177-82. PubMed ID: 2066105
[TBL] [Abstract][Full Text] [Related]
2. [Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].
Mazin AL
Mol Biol (Mosk); 1995; 29(1):71-90. PubMed ID: 7723765
[TBL] [Abstract][Full Text] [Related]
3. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.
Koeberl DD; Bottema CD; Ketterling RP; Bridge PJ; Lillicrap DP; Sommer SS
Am J Hum Genet; 1990 Aug; 47(2):202-17. PubMed ID: 2198809
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
[TBL] [Abstract][Full Text] [Related]
7. Haplotype analysis of identical factor IX mutants using PCR.
Green PM; Montandon AJ; Ljung R; Nilsson IM; Giannelli F
Thromb Haemost; 1992 Jan; 67(1):66-9. PubMed ID: 1615486
[TBL] [Abstract][Full Text] [Related]
8. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
[TBL] [Abstract][Full Text] [Related]
9. Characterization of factor IX defects in hemophilia B patients.
Thompson AR; Chen SH
Methods Enzymol; 1993; 222():143-69. PubMed ID: 8412791
[No Abstract] [Full Text] [Related]
10. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
Tanimoto M; Matsushita T; Takamatsu J; Saito H
Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in factor IX gene from western India with reference to their phenotypic and haplotypic attributes.
Quadros L; Ghosh K; Shetty S
J Pediatr Hematol Oncol; 2009 Mar; 31(3):157-60. PubMed ID: 19262239
[TBL] [Abstract][Full Text] [Related]
12. Factor IXPortland: a nonsense mutation (CGA to TGA) resulting in hemophilia B.
Chen SH; Scott CR; Schoof J; Lovrien EW; Kurachi K
Am J Hum Genet; 1989 Apr; 44(4):567-9. PubMed ID: 2929599
[TBL] [Abstract][Full Text] [Related]
13. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
[TBL] [Abstract][Full Text] [Related]
14. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
Tartary M; Vidaud D; Piao Y; Costa JM; Bahnak BR; Fressinaud E; Congard B; Laurian Y; Meyer D; Lavergne JM
Br J Haematol; 1993 Aug; 84(4):662-9. PubMed ID: 8217825
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in four hemophilia B patients from China.
Wang NS; Chen SH; Thompson AR
Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
[TBL] [Abstract][Full Text] [Related]
17. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
[TBL] [Abstract][Full Text] [Related]
18. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
Bottema CD; Ketterling RP; Vielhaber E; Yoon HS; Gostout B; Jacobson DP; Shapiro A; Sommer SS
Hum Genet; 1993 Jun; 91(5):496-503. PubMed ID: 8314564
[TBL] [Abstract][Full Text] [Related]
19. T296----M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection.
Ketterling RP; Bottema CD; Koeberl DD; Ii S; Sommer SS
Hum Genet; 1991 Jul; 87(3):333-7. PubMed ID: 1864609
[TBL] [Abstract][Full Text] [Related]
20. DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
Matsushita T; Tanimoto M; Yamamoto K; Sugiura I; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
J Lab Clin Med; 1990 Oct; 116(4):492-7. PubMed ID: 2212858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
